author-photo

Frédéric Pouliot

Laval University
University of California, Los Angeles

207

Papers

3564

Citations

Citation Trend

Filter By

Papers (149) Sort By

Journal Conference Others

Interpreting Testosterone and Concomitant Prostate Specific Antigen Values during Androgen Deprivation Therapy for Recurrent Prostate Cancer.

2021 The Journal of Urology
Show All
- Source
- Cite
- Save
Citations (0)
MP11-11 CHANGES TO INITIAL RISK ASSESSMENT AND INTENDED PATIENT MANAGEMENT IN HIGH-RISK PROSTATE CANCER: AN EXPLORATORY ANALYSIS OF COHORT A FROM THE OSPREY TRIAL

2021 The Journal of Urology
Show All
- Source
- Cite
- Save
Citations (0)
Adrenalectomy During Radical Nephrectomy- Incidence and Oncologic Outcomes from the Canadian Kidney Cancer Information System (CKCis) -A Modern Era, Nationwide, Multicenter Cohort.

2021 Urology
Show All
- Source
- Cite
- Save
Citations (0)
Pembrolizumab (pembro) plus axitinib (axi) versus sunitinib as first-line therapy for advanced clear cell renal cell carcinoma (ccRCC): Results from 42-month follow-up of KEYNOTE-426.

2021 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (11)
A Phase 2/3 Prospective Multicenter Study of the Diagnostic Accuracy of Prostate-Specific Membrane Antigen PET/CT with 18F-DCFPyL in Prostate Cancer Patients (OSPREY).

2021 The Journal of Urology
Show All
- Source
- Cite
- Save
Citations (18)
Results from a Canadian consensus forum of key controversial areas in the management of advanced prostate cancer: Recommendations for Canadian healthcare providers.

2021 Cuaj-canadian Urological Association Journal
Show All
- Source
- Cite
- Save
Citations (0)
Outcomes for patients in the pembrolizumab+axitinib arm with advanced renal cell carcinoma (RCC) who completed two years of treatment in the phase III KEYNOTE-426 study.

2021 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (2)
Proximity-dependent mapping of the Androgen Receptor identifies Kruppel-Like Factor 4 as a functional partner.

2021 Molecular & Cellular Proteomics
Show All
- Source
- Cite
- Save
Citations (1)
The increasing use of renal tumor biopsy amongst Canadian urologists: When is biopsy most utilized?

2021 Urologic Oncology-seminars and Original Investigations
Show All
- Source
- Cite
- Save
Citations (0)
A prospective phase II/III study of PSMA-targeted 18F-DCFPyL-PET/CT in patients (pts) with prostate cancer (PCa) (OSPREY): A subanalysis of disease staging changes in PCa pts with recurrence or metastases on conventional imaging.

2021 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (0)